IMRX Insider Trading

Insider Ownership Percentage: 25.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Immuneering Insider Trading History Chart

This chart shows the insider buying and selling history at Immuneering by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Immuneering Share Price & Price History

Current Price: $1.29
Price Change: Price Increase of +0.05 (4.03%)
As of 04/11/2025 05:00 PM ET

This chart shows the closing price history over time for IMRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$1.29Closing price on 04/11/25:

SEC Filings (Institutional Ownership Changes) for Immuneering (NASDAQ:IMRX)

67.65% of Immuneering stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$419kbought$250ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal InflowsTotal Outflows
Immuneering logo
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Read More on Immuneering

Today's Range

Now: $1.29
Low: $1.23
High: $1.34

50 Day Range

MA: $1.61
Low: $1.24
High: $1.99

52 Week Range

Now: $1.29
Low: $1.00
High: $3.83

Volume

140,870 shs

Average Volume

2,349,749 shs

Market Capitalization

$46.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immuneering?

Immuneering's top insider shareholders include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Benjamin J Zeskind (CEO)
  3. Peter Feinberg (Director)
  4. Ann E Berman (Director)
  5. Leah R Neufeld (Insider)
  6. Mallory Morales (CAO)
  7. Harold Eugene Brakewood (Insider)
Learn More about top insider investors at Immuneering.